WA
EXAS

Waddell & Associates’s Exact Sciences EXAS Stock Holding History

Waddell & Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,110
Closed -$519K – 466
2025
Q4 		$519K Buy
+5,110
New +$410K 0.04% 164

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Waddell & Associates's EXAS Position: Q1 2026 in Review

Waddell & Associates sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 5,110 shares — an estimated $519K sold.

Waddell & Associates first reported a position in EXAS in Q4 2025 and held it in 1 quarter. The position peaked at $519K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Waddell & Associates reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Waddell & Associates sold 5,110 Exact Sciences shares in Q1 2026, an estimated $519K.
  • Waddell & Associates first reported a position in Exact Sciences in Q4 2025 and held it in 1 quarter.
  • Waddell & Associates's Exact Sciences position peaked at $519K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Waddell & Associates's 13F filing for Q1 2026, filed 11 May 2026.